In a 2022 study on lung cancer stem-like cells, siRNA-mediated VDAC1 knockdown resulted in metabolic reprogramming, characterized by a shift from OXPHOS to glycolysis, ultimately impairing tumor progression [56]. Here, VDAC1 is linked to lung cancer.